Spirocyclic inhibitors of hepatitis b virus
Номер патента: EP4103567A1
Опубликовано: 21-12-2022
Автор(ы): Adolfo Prandi, Leda Ivanova BENCHEVA, Lorena DONNICI, Luca GUIDOTTI, Marilenia De Matteo, Matteo Iannacone, Pietro RANDAZZO, Raffaele De Francesco, Romano Di Fabio, Vincenzo Summa
Принадлежит: Istituto Nazionale di Genetica Molecolare INGM, Ospedale San Raffaele SRL
Опубликовано: 21-12-2022
Автор(ы): Adolfo Prandi, Leda Ivanova BENCHEVA, Lorena DONNICI, Luca GUIDOTTI, Marilenia De Matteo, Matteo Iannacone, Pietro RANDAZZO, Raffaele De Francesco, Romano Di Fabio, Vincenzo Summa
Принадлежит: Istituto Nazionale di Genetica Molecolare INGM, Ospedale San Raffaele SRL
Реферат: The present invention relates to compounds that are inhibitors of hepatitis B virus (HBV). Compounds of this invention are useful alone or in combination with other agents for treating, ameliorating preventing or curing HBV infection and related conditions. The present invention also relates to pharmaceutical compositions containing said compounds.
CYCLED SULFAMOILARILAMIDE DERIVATIVES AND ITS USE AS MEDICATIONS FOR THE TREATMENT OF HEPATITIS B
Номер патента: CR20180069A. Автор: Pierre Jean-Marie Bernard Raboisson,Koen Vandyck,Serge Maria Aloysius Pieters,Sandrine Marie Helene Vendeville,Samuël Dominique DEMIN,Stefaan Julien Last,Lili Hu,Geerwin Yvonne Paul HACHÉ,Geert Rombouts,Sandrine Céline GROSSE,Win Gaston Verschueren. Владелец: JANSSEN SCIENCES IRELAND UC. Дата публикации: 2018-06-27.